Skip to content
Open access · CC-BY via OpenAlex

Activated carbon N-acetylcysteine microcapsule protects against nonalcoholic fatty liver disease in young rats via activating telomerase and inhibiting apoptosis

Tingting Shi, Xingxin Yang, Hongping Zhou, Jianjun Xi, Jingjing Sun, Yunling Ke, Jiankang Zhang, Yidan Shao, Xiaojie Jiang, Xuwang Pan, Shourong Liu, Rangxiao Zhuang

PLoS ONE · 2018 · ▲ 19 citations

Abstract

Non-alcoholic fatty liver disease (NAFLD) is becoming one of the world's most common chronic liver diseases in childhood, yet no therapy is available that has been approved by the food and drug administration (FDA). Previous studies have reported that telomere(definition) and telomerase are involved the development and progression of NAFLD. This study was designed to investigate the potential beneficial effects of activated carbon N-acetylcysteine (ACNAC) microcapsules on the development of NAFLD in young rats as well as the underlying mechanism(s) involved. Three-week old male Sprague Dawley rats were given high-fat diet (HFD) with/without ACNAC treatment for 7 consecutive weeks. Liver pathologies were determined by hematoxylin and eosin (H&E) and Oil Red O staining, as well as by changes in biochemical parameters of plasma alanine transaminase (ALT) and aspartate transaminase (AST) levels, respectively. Glucose homeostasis was evaluated by the glucose tolerance test and the liver telomere length and activity were measured by real time PCR and telomeric repeat amplification protocol (TRAP). Western blot analysis was performed to determine the expression level of Bcl-2, Bax and Caspase-3. Our results demonstrated that ACNAC supplementation improved liver pathologies of rats that received long-term HFD feeding. ACNAC supplementation prevented HFD-induced telomere shortening and improved telomerase activity. Moreover, in comparison to HFD-fed rats, ACNAC supplementation markedly increased the expression of Bcl-2, but significantly decreased the expression of Bax and Caspase-3 in juvenile rats. Together, these results indicate that ACNAC may be a promising choice for preventing and treating NAFLD among children.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1371/journal.pone.0189856
Canonical
link ↗
Fetched
2026-10-10 MST

Cite this

APA
Shi, T., Yang, X., Zhou, H., Xi, J., Sun, J., Ke, Y., Zhang, J., Shao, Y., Jiang, X., Pan, X., Liu, S., &amp; Zhuang, R. (2018). Activated carbon N-acetylcysteine microcapsule protects against nonalcoholic fatty liver disease in young rats via activating telomerase and inhibiting apoptosis. <em>PLoS ONE</em>. https://doi.org/10.1371/journal.pone.0189856
Vancouver
Shi T, Yang X, Zhou H, Xi J, Sun J, Ke Y, et al. Activated carbon N-acetylcysteine microcapsule protects against nonalcoholic fatty liver disease in young rats via activating telomerase and inhibiting apoptosis. PLoS ONE. 2018. doi:10.1371/journal.pone.0189856.
BibTeX
@article{tingting2018Activa, title = {Activated carbon N-acetylcysteine microcapsule protects against nonalcoholic fatty liver disease in young rats via activating telomerase and inhibiting apoptosis}, author = {Tingting Shi and Xingxin Yang and Hongping Zhou and Jianjun Xi and Jingjing Sun and Yunling Ke and Jiankang Zhang and Yidan Shao and Xiaojie Jiang and Xuwang Pan and Shourong Liu and Rangxiao Zhuang}, journal = {PLoS ONE}, year = {2018}, doi = {10.1371/journal.pone.0189856}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings